Amgen CDR (CAD Hedged) (AMGN:TSX) closed at $32.45 on October 23, 2026, down 1.96% on the day. The stock trades 2.1% below its 52-week high of $33.16 and 35.5% above its 52-week low of $23.95. Over the past year, it gained 29.7%. Amgen CDR (CAD Hedged) is part of the Health Care sector.
In 208 trading sessions since December 24, 2025, AMGN closed higher on 98 days (47%). Its best day was February 4, 2026 (+7.58%) and its worst was September 8, 2026 (-10.17%). The stock moved 10% or more in a single session 1 time. It opened at least 5% above the previous day's high 4 times.
Amgen discovers, develops, manufactures and delivers innovative medicines to help millions of patients in their fight against some of the world's toughest diseases. More than 40 years ago, Amgen helped to establish the biotechnology industry and remains on the cutting-edge of innovation, using technology and human genetic data to push beyond what's known today. Amgen is advancing a broad and deep pipeline that builds on its existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases.
Find more stocks like AMGN with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.